Ada Cleary Sher
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ada Cleary Sher has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Tendy Chiang
Center for Regenerative Medicine Abigail Wexner Research Institute, Nationwide Children's Hospital Columbus Ohio USA
3 shared publications - Lumei Liu
Center of Regenerative Medicine, Abigail Wexner Research Institute, Nationwide Children’s Hospital, Columbus, OH, USA
2 shared publications Amy Manning
Department of Pediatric Otolaryngology Nationwide Children's Hospital Columbus Ohio USA
1 shared publicationAudrey Miller
Department of Pediatrics, Division of Neonatology Nationwide Children's Hospital Columbus Ohio USA
1 shared publicationHajera Afreen
The Ohio State University College of Medicine Columbus Ohio USA
1 shared publicationHumra Shamim
Center for Regenerative Medicine, Abigail Wexner Research Institute Nationwide Children's Hospital Columbus Ohio USA
1 shared publication
Latest Publications
- 23 April 2026
- Published by SAGE Publications in Annals of Otology, Rhinology & Laryngology
- Vol. 135 (9) , 698-706
Surgery-Induced Stress Promotes SOX9 Nuclear Localization and Increases COL2A1 in Tracheal Cartilage
Objective: Airway reconstruction triggers a surgery-induced stress (SIS) response, but its effect on cartilage regeneration remains elusive. SOX9 regulates cartilage regeneration by promoting type II collagen production and may aid in repair; however, the role of SOX9 in response to SIS is unclear. We utilized a mouse model to validate SOX9 nuclear expression in tracheal chondrocytes and assess its localization after segmental tracheal replacement. Methods: Tracheas from C57BL/6J mice were digested using Dispase-Collagenase-Trypsin, then collagenase II to isolate chondrocytes for primary culture. Syngeneic tracheal grafts were harvested from donor animals, and a 3 to 4 mm tracheal graft was implanted orthotopically to assess chondrocyte function in vivo. At 1 month, graft, anastomosis, and adjacent host tissues were harvested. Samples were stained for SOX9 and COL2A1, and their localization was analyzed with ImageJ. Results: Primary tracheal chondrocytes showed strong nuclear SOX9 and cytoplasmic COL2A1 expression. One month after orthotopic tracheal replacement, SOX9 nuclear colocalization increased in the host and anastomosis regions ( P = .0269 and P = .0262, respectively), but not in the graft ( P = .5958). COL2A1 intensity in the cartilage matrix was significantly higher in graft, host, and anastomosis compared to native cartilage (all P < .01), with no morphological differences. Conclusion: After tracheal reconstruction, increased SOX9 and COL2A1 intensities indicate a potential chondrocyte response to SIS. SOX9 nuclear localization may be involved in regulating COL2A1 in tracheal chondrocytes during cartilage injury and repair. This supports a possible role for SOX9 in maintaining cartilage function and its potential as a therapeutic target to improve graft integration and airway stability.
- 23 April 2026
- Published by SAGE Publications in Annals of Otology, Rhinology & Laryngology
- Vol. 135 (9) , 698-706
Surgery-Induced Stress Promotes SOX9 Nuclear Localization and Increases COL2A1 in Tracheal Cartilage
Objective: Airway reconstruction triggers a surgery-induced stress (SIS) response, but its effect on cartilage regeneration remains elusive. SOX9 regulates cartilage regeneration by promoting type II collagen production and may aid in repair; however, the role of SOX9 in response to SIS is unclear. We utilized a mouse model to validate SOX9 nuclear expression in tracheal chondrocytes and assess its localization after segmental tracheal replacement. Methods: Tracheas from C57BL/6J mice were digested using Dispase-Collagenase-Trypsin, then collagenase II to isolate chondrocytes for primary culture. Syngeneic tracheal grafts were harvested from donor animals, and a 3 to 4 mm tracheal graft was implanted orthotopically to assess chondrocyte function in vivo. At 1 month, graft, anastomosis, and adjacent host tissues were harvested. Samples were stained for SOX9 and COL2A1, and their localization was analyzed with ImageJ. Results: Primary tracheal chondrocytes showed strong nuclear SOX9 and cytoplasmic COL2A1 expression. One month after orthotopic tracheal replacement, SOX9 nuclear colocalization increased in the host and anastomosis regions ( P = .0269 and P = .0262, respectively), but not in the graft ( P = .5958). COL2A1 intensity in the cartilage matrix was significantly higher in graft, host, and anastomosis compared to native cartilage (all P < .01), with no morphological differences. Conclusion: After tracheal reconstruction, increased SOX9 and COL2A1 intensities indicate a potential chondrocyte response to SIS. SOX9 nuclear localization may be involved in regulating COL2A1 in tracheal chondrocytes during cartilage injury and repair. This supports a possible role for SOX9 in maintaining cartilage function and its potential as a therapeutic target to improve graft integration and airway stability.
- Open Access
- 10 April 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 173 (2) , 487-496
Tracheostomy Outcomes in Children With Bronchopulmonary Dysplasia
Objective: To quantify the tracheostomy‐related morbidity and mortality, readmissions, and airway interventions in tracheostomy‐dependent children with bronchopulmonary dysplasia (BPD).Study Design: Retrospective chart review.Setting: Tertiary care children's hospital.Methods: Infants with BPD who received tracheostomy by an otolaryngologist between January 2016 and December 2022 at a single institution were included. Surviving patients were followed to at least 2 years of age. Data were extracted from electronic medical records for patient characteristics, clinical encounters, and surgical visits.Results: There were 76 patients included in this study. The overall mortality was 30.3% (23/76) with one tracheostomy‐related death. Tracheostomy occurred at a median 56 weeks postmenstrual age (PMA). Tracheitis was the most common short‐ and long‐term adverse event (within the first postoperative week, 21%; after postoperative day 7, 81%). Other complications observed include stomal granuloma (77%), airway stenosis (69%), and accidental decannulation (38%). The 30‐day and 2‐year readmission rates were 32% and 61%, of which 61% and 76% were for tracheostomy‐related causes, respectively. The most common reason for readmission over these time periods was tracheitis. Overall decannulation rate for surviving patients was 68%, and decannulation occurred at a median 3.1 years of age. Most surviving patients returned for operative airway intervention (85%); 43% required open airway reconstruction.Conclusion: Tracheostomy‐related morbidity was low in this cohort despite a majority of patients experiencing multiple tracheostomy‐related adverse events and readmissions. Patient comorbid conditions, BPD severity, and socioeconomic status were not significantly associated with outcomes. Larger studies are needed to assess the airway interventions and outcomes in this population.
- 10 April 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 173 (2) , 487-496
Open AccessTracheostomy Outcomes in Children With Bronchopulmonary Dysplasia
Objective: To quantify the tracheostomy‐related morbidity and mortality, readmissions, and airway interventions in tracheostomy‐dependent children with bronchopulmonary dysplasia (BPD).Study Design: Retrospective chart review.Setting: Tertiary care children's hospital.Methods: Infants with BPD who received tracheostomy by an otolaryngologist between January 2016 and December 2022 at a single institution were included. Surviving patients were followed to at least 2 years of age. Data were extracted from electronic medical records for patient characteristics, clinical encounters, and surgical visits.Results: There were 76 patients included in this study. The overall mortality was 30.3% (23/76) with one tracheostomy‐related death. Tracheostomy occurred at a median 56 weeks postmenstrual age (PMA). Tracheitis was the most common short‐ and long‐term adverse event (within the first postoperative week, 21%; after postoperative day 7, 81%). Other complications observed include stomal granuloma (77%), airway stenosis (69%), and accidental decannulation (38%). The 30‐day and 2‐year readmission rates were 32% and 61%, of which 61% and 76% were for tracheostomy‐related causes, respectively. The most common reason for readmission over these time periods was tracheitis. Overall decannulation rate for surviving patients was 68%, and decannulation occurred at a median 3.1 years of age. Most surviving patients returned for operative airway intervention (85%); 43% required open airway reconstruction.Conclusion: Tracheostomy‐related morbidity was low in this cohort despite a majority of patients experiencing multiple tracheostomy‐related adverse events and readmissions. Patient comorbid conditions, BPD severity, and socioeconomic status were not significantly associated with outcomes. Larger studies are needed to assess the airway interventions and outcomes in this population.
- 5 October 2024
- Published by Wiley in The Laryngoscope
- Vol. 135 (2) , 614-621
Microvascular Regeneration and Perfusion of Partially Decellularized Tracheal Grafts
Objectives: A critical barrier to successful tracheal transplantation is poor vascularization. Despite its importance, little is known about microvascular regeneration in tissue‐engineered grafts. We have demonstrated that partially decellularized tracheal grafts (PDTG) support neotissue formation including new submucosal microvasculature (CD31+). However, the perfusion of this neovasculature is unknown. In this study, we used a mouse model of tracheal replacement to measure the microvascular regeneration and perfusion of PDTG.Methods: PDTG and syngeneic tracheal grafts (STG, surgical control) (n = 5 for each group) were orthotopically transplanted into C5BL/6 J mice. We quantified vascularity of STG and PDTG samples at 1 and 3 months with conventional histology (N = 3 ~ 10/group). At 1, 3, and 6 months, animals were injected with fluorescein isothiocyanate (FITC) tomato lectin into the left ventricle. After perfusion, tracheas were fixed, harvested, mounted, stained for CD31 expression, and imaged with resonant scanning confocal microscopy. Percent CD31+, FITC area was compared between groups and endpoints compared with native trachea. Microvascular intersections were quantified using Sholl analysis.Results: Functional microvasculature was seen in both groups. Although percent vascularization (CD31) in PDTG was restored by 3 months, microvascular pattern in PDTG displayed a unique morphology compared with control. Surgery alone appeared to globally change microvascular pattern and perfusion. PDTG demonstrated equivalent perfusion to surgical control by 6 months. Sholl analysis revealed a reduction of microvessel intersectionality that persisted in PDTG and was not seen in surgical or native controls.Conclusions: PDTG exhibited microvascular regeneration. Perfusion was present in PDTG, improved, and persisted over long‐term time points.Level of Evidence: NA Laryngoscope, 135:614–621, 2025
- 5 October 2024
- Published by Wiley in The Laryngoscope
- Vol. 135 (2) , 614-621
Microvascular Regeneration and Perfusion of Partially Decellularized Tracheal Grafts
Objectives: A critical barrier to successful tracheal transplantation is poor vascularization. Despite its importance, little is known about microvascular regeneration in tissue‐engineered grafts. We have demonstrated that partially decellularized tracheal grafts (PDTG) support neotissue formation including new submucosal microvasculature (CD31+). However, the perfusion of this neovasculature is unknown. In this study, we used a mouse model of tracheal replacement to measure the microvascular regeneration and perfusion of PDTG.Methods: PDTG and syngeneic tracheal grafts (STG, surgical control) (n = 5 for each group) were orthotopically transplanted into C5BL/6 J mice. We quantified vascularity of STG and PDTG samples at 1 and 3 months with conventional histology (N = 3 ~ 10/group). At 1, 3, and 6 months, animals were injected with fluorescein isothiocyanate (FITC) tomato lectin into the left ventricle. After perfusion, tracheas were fixed, harvested, mounted, stained for CD31 expression, and imaged with resonant scanning confocal microscopy. Percent CD31+, FITC area was compared between groups and endpoints compared with native trachea. Microvascular intersections were quantified using Sholl analysis.Results: Functional microvasculature was seen in both groups. Although percent vascularization (CD31) in PDTG was restored by 3 months, microvascular pattern in PDTG displayed a unique morphology compared with control. Surgery alone appeared to globally change microvascular pattern and perfusion. PDTG demonstrated equivalent perfusion to surgical control by 6 months. Sholl analysis revealed a reduction of microvessel intersectionality that persisted in PDTG and was not seen in surgical or native controls.Conclusions: PDTG exhibited microvascular regeneration. Perfusion was present in PDTG, improved, and persisted over long‐term time points.Level of Evidence: NA Laryngoscope, 135:614–621, 2025
- Open Access
- 1 July 2024
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 33 (173) , 240073
In vivodetection of pulmonary mucociliary clearance: present challenges and future directions
Pulmonary mucociliary clearance (MCC) is an important defence mechanism of the respiratory system and clears pathogens and foreign particles from the airways. Understanding the effect of disease states, drugs, toxins and airway manipulations on MCC could be beneficial in preventing early pulmonary disease and developing new pulmonary therapeutics. This review summarises the current methods and future efforts to detect pulmonary MCCin vivo.
- 1 July 2024
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 33 (173) , 240073
Open AccessIn vivodetection of pulmonary mucociliary clearance: present challenges and future directions
Pulmonary mucociliary clearance (MCC) is an important defence mechanism of the respiratory system and clears pathogens and foreign particles from the airways. Understanding the effect of disease states, drugs, toxins and airway manipulations on MCC could be beneficial in preventing early pulmonary disease and developing new pulmonary therapeutics. This review summarises the current methods and future efforts to detect pulmonary MCCin vivo.